Skip to content
OpenCapital
Get started

LivaNova LIVN EPS (Diluted)

EPS (Diluted) at other companies

Abbott logo
AbbottABT
$0.61-19.7%
Medtronic logo
MedtronicMDT
$0.97+18.3%
Boston Scientific logo
Boston ScientificBSX
$0.90+100%
Stryker logo
StrykerSYK
$1.93+14.2%
Merit Medical Systems logo
Merit Medical SystemsMMSI
$0.68+38.8%
Xenon Pharmaceuticals logo
Xenon PharmaceuticalsXENE
-$1.17-41.0%

Other financials

Income statement

See full
Revenue$362.3M+14.3%
Gross profit$243.7M+12.7%
Operating income$41.5M-14.7%
Net income$22.3M+107%

Balance sheet

See full
Cash & equivalents$539.7M-26.9%
Total debt$340.9M-49.7%
Total equity$1.2B+17.1%
Total assets$2.5B-1.7%

Cash flow

See full
Operating cash flow$15.2M-36.5%
CapEx$14.3M+32.4%
Free cash flow$926.0K-93.0%

Valuation

See full
Market cap$4.31B+62.8%
Enterprise value$4.11B+58.0%
P/S3×+0.9×

Profitability

See full
Gross margin67.5%-0.5pp
Operating margin13.4%+0.8pp
Net margin-16.1%-18.0pp
FCF margin11.2%-0.2pp

Returns & leverage

See full
Return on equity-17.6%-19.5pp
Debt / equity0.3×-0.4×
Current ratio1.3×-0.2×

Where this comes from

Reported directly by LivaNova in its filing.

Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.

The official record: LivaNova’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about LivaNova's eps (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is LivaNova's EPS (diluted)?
LivaNova (LIVN) reported EPS (diluted) of $0.40 in Q1 2026.
How has LivaNova's EPS (diluted) changed year-over-year?
LivaNova's EPS (diluted) increased by 106.7% year-over-year, from -$6.01 to $0.40.
What is the long-term trend for LivaNova's EPS (diluted)?
Over 3 years (2021 to 2024), LivaNova's EPS (diluted) has grown at a -24.9% compound annual growth rate (CAGR), from -$2.72 to $1.15.
What does EPS (diluted) mean?
Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.